COPD Highlights vom ATS Kongres 2020

COPD Highlights vom ATS Kongres 2020

-Diagnosis
   Risk assessment through airway counting
   Analysis of hyperinflation from spirometry
   Prognosis - role of reduced DLCO

- Comorbidities - cardiovascular system diastolic dysfunction and
   > hospital admissions
   > pulmonary dysfunction

- Muscle assessment using CT

- antibodies against pneumococci and exacerbations

- pharmacological treatment
   > LABA / LAMA vs single substances and short vs long-term effects
   > Triple vs LABA / ICS vs LABA / LAMA - ETHOS
   > LABA / LAMA vs LABA / ICS and LABA / LAMA vs LABA / LAMA / ICS